Published in A&A Case Reports: 1 December 2014 – Volume 3 – Issue 11 – p 142–144 Authors: Curatolo, Christopher MD, MEM; Trinh, Muoi MD, MPH Patients receiving extended-release (XR) naltrexone who are having surgery present unique challenges to anesthesia providers, the most obvious of which is an altered response to the effects of opioid […]
Read MoreEtomidate is a hypnotic agent used for the induction of general anesthesia and is commonly used for rapid sequence intubation (RSI). Medications used in RSI can contribute to hypotension after intubation, which has been shown to be associated with increases in mortality. Although it has been reported that etomidate is associated with hemodynamic stability after […]
Read MorePostoperative delirium might be associated with cognitive decline 4 to 6 weeks after cardiac surgery, a rigorous analysis has shown. “The prevention of postoperative delirium may be a strategy for avoiding cognitive decline,” said lead investigator Charles Brown, MD, from the Johns Hopkins University School of Medicine in Baltimore. Dr Brown pointed out that delirium […]
Read MorePublished in Lancet Neurol 2015 Feb 14:162 Authors: Finnerup NB et al. Results of a meta-analysis and systematic review Neuropathic pain is a serious chronic condition affecting quality of life that can be relieved but not cured. The estimated prevalence is at least 1% to 5% of the general population (Pain Pract 2014; 14:283). Neuropathic pain results […]
Read MoreOpioids like OxyContin pills are the single largest cause of overdose fatalities in the nation. The federal health authorities reported that nearly one-third of women of reproductive age had had an opioid painkiller prescription filled every year from 2008 to 2012. Experts said the practice carried considerable risks for birth defects. The Centers for Disease […]
Read More